{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:20:12Z","timestamp":1762521612668},"reference-count":76,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.gastrohep.2013.06.005","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T00:18:59Z","timestamp":1378340339000},"page":"587-596","source":"Crossref","is-referenced-by-count":5,"title":["Esteatohepatitis alcoh\u00f3lica y no alcoh\u00f3lica: \u00bfqui\u00e9nes son los pacientes y qu\u00e9 podemos hacer por ellos?"],"prefix":"10.1016","volume":"36","author":[{"given":"Roc\u00edo","family":"Gallego-Dur\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ampuero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Funuyet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Romero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2013.06.005_bib0005","doi-asserted-by":"crossref","first-page":"1001324","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Spelliotes","year":"2011","journal-title":"PLos Genet"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0010","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: Old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: A population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0020","first-page":"2023","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases","volume":"2005","author":"Chalasani","year":"2012","journal-title":"American College of Gastroenterology, and the American Gastroenterological Association. Hepatology."},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0025","first-page":"11","article-title":"Validaci\u00f3n de la prueba para la identificaci\u00f3n de trastornos por el uso de alcohol (AUDIT) en atenci\u00f3n primaria","volume":"198","author":"Rubio","year":"1998","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.15288\/jsa.1995.56.423","article-title":"The Alcohol Use Disorders Identification Test (AUDIT): Validation of a screening instrument for use in medical settings","volume":"56","author":"Bohn","year":"1995","journal-title":"J Stud Alcohol"},{"issue":"Supl 1","key":"10.1016\/j.gastrohep.2013.06.005_bib0035","first-page":"37","article-title":"Marcadores biol\u00f3gicos de la conducta alcoh\u00f3lica","volume":"5","author":"Saiz","year":"1998","journal-title":"Psiquiatr Biol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0040","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1360-0443.2005.01216.x","volume":"100","author":"Hock","year":"2005","journal-title":"Addiction"},{"year":"2005","series-title":"Gu\u00eda de Referencia R\u00e1pida para abordar el Consumo de Alcohol","key":"10.1016\/j.gastrohep.2013.06.005_bib0045"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0050","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0055","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1007\/s00330-006-0146-0","article-title":"Fat in the liver, diagnosis and characterization","volume":"16","author":"Valls","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/bjs.6479","article-title":"Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy","volume":"96","author":"Nagai","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0065","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/pr201223p","article-title":"Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression","volume":"11","author":"Barr","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0070","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noinvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0075","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/hep.22896","article-title":"Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"49","author":"Milner","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0080","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","article-title":"Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride","volume":"53","author":"Li","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0085","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jhep.2011.12.025","article-title":"Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers","volume":"56","author":"Shen","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0090","first-page":"187","article-title":"Noninvasive biomarkers for the screening of fibrosis. steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMaxTM Experience","volume":"17","author":"Monteanu","year":"2008","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0095","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stifness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2009.05.023","article-title":"Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance","volume":"51","author":"Schwenzer","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2214\/AJR.07.2123","article-title":"Interobserver and intraobserver variability in the sonographic assessment of fatty liver","volume":"189","author":"Strauss","year":"2007","journal-title":"Am J Roetgenol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2010.01.008","article-title":"Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations","volume":"52","author":"Lee","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0115","first-page":"S1","article-title":"Determination of fibrosis stage and steatohepatitis in patients with NAFLD by optical analysis of magnetic resonance images combined with artificial neural networks (FIBROMRi and NAHMRi)","volume":"58 Supl. 1","author":"Gallego-Dur\u00e1n","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0120","first-page":"874","article-title":"Effect of moderate alcohol consumption on the development of non-alcoholic fatty liver disease (NAFLD) in ob\/ob mice","volume":"56","author":"Kanuri","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2036.2010.04520.x","article-title":"Alcohol consumption appears to protect against non-alcoholic fatty liver disease","volume":"33","author":"Moriya","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2131\/jts.32.453","article-title":"Common pathogenic mechanism in development progression of liver injurycaused bynon-alcoholic or alcoholic steatohepatitis","volume":"32","author":"Nagata","year":"2007","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0135","first-page":"83","article-title":"Alcoholic and nonalcoholic forms of fatty liver disease","volume":"53","author":"Forgione","year":"2007","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0140","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.3748\/wjg.v18.i27.3492","article-title":"Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?","volume":"18","author":"V\u00f6lzke","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0145","first-page":"300","article-title":"Endotoxin and Kupffer cell activation in alcoholic liver disease","volume":"27","author":"Wheeler","year":"2003","journal-title":"Alcohol Res Health"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/hep.510310219","article-title":"The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat","volume":"31","author":"Iimuro","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0155","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","article-title":"CYP2E1 and oxidative liver injury by alcohol","volume":"44","author":"Lu","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0160","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \u00abhits\u00bb?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0165","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","article-title":"Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role","volume":"35","author":"Aubert","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/dmd.107.017731","article-title":"Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and highsucrose diet","volume":"36","author":"Osabe","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0175","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jn\/138.8.1452","article-title":"Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake","volume":"138","author":"Thuy","year":"2008","journal-title":"J Nutr"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0185","first-page":"759","article-title":"Compensatory alterations for insulin signal transduction and glucose transport in insulin-resistant diabetes","volume":"269","author":"Bonini","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0190","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/MCB.17.3.1595","article-title":"Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt","volume":"17","author":"Kulik","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"Suppl 2","key":"10.1016\/j.gastrohep.2013.06.005_bib0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1746.2011.07023.x","article-title":"Alcohol, insulin resistance and the liver-brain axis","volume":"27","author":"de la Monte","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0200","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1440-1746.2008.05339.x","article-title":"Insulin resistance in experimental alcohol-induced liver disease","volume":"23","author":"De la Monte","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0205","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI24930","article-title":"Contribution of adipose tissue and de novo lipogenesis to non alcoholic fatty liver disease","volume":"115","author":"Tamura","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0210","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3109\/00365521.2011.613945","article-title":"Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice","volume":"46","author":"Frederico","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0215","first-page":"232","article-title":"Human fatty liver disease: old questions and new insights","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2010.10.024","article-title":"Distinct regulation of adiponutrin\/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes","volume":"55","author":"Dubuquoy","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0225","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0230","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hep.24017","article-title":"Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians","volume":"53","author":"Stickel","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0235","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2011.01.028","article-title":"Common polymorphism in the PNPLA3\/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease","volume":"55","author":"Tr\u00e9po","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0240","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Abu-Shanab","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0245","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0250","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0255","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology."},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0260","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.dld.2010.01.021","article-title":"Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Commitee","volume":"42","author":"Loria","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review","volume":"56","author":"Thoma","year":"2012","journal-title":"J Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0270","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2007.06.020","article-title":"Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study","volume":"47","author":"Zelber-Sagi","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0275","doi-asserted-by":"crossref","first-page":"e46819","DOI":"10.1371\/journal.pone.0046819","article-title":"Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults","volume":"7","author":"Bae","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0280","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1600-0676.2003.01804.x","article-title":"Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence","volume":"23","author":"Pessione","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0290","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0168-8278(05)80221-1","article-title":"Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls","volume":"17","author":"Zillikens","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0295","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1440-1746.2005.04233.x","article-title":"Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis","volume":"21","author":"Sreenivasa Baba","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0300","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled clinical trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Fromrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0305","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.2337\/dc10-0856","article-title":"Effect on a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type-2 diabetes","volume":"33","author":"Lazo","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0310","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(01)06042-1","article-title":"Metformin in non-alcoholic steatohepatitis","volume":"358","author":"Marchesini","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2036.2004.02025.x","article-title":"Metformin in the treatment of non-alcoholic steatohepatitis: A pilot open label trial","volume":"20","author":"Nair","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0320","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0325","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0330","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases. American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0335","article-title":"Chronic alcohol-induced hepatic insulin resistance and ER stress ameliorated by PPAR-\u03b4 agonist treatment","author":"Ramirez","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0340","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/jhep.2003.50420","article-title":"Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone","volume":"38","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0345","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0350","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0355","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.mam.2007.05.004","article-title":"Vitamin E: An overview of major research directions","volume":"28","author":"Zingg","year":"2007","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0360","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.1840040521","article-title":"Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats","volume":"4","author":"French","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0365","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/07315724.1995.10718493","article-title":"Effects of long-term vitamin E supplementation in alcoholic cirrhotics","volume":"14","author":"de la Maza","year":"1995","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0370","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0375","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jama.297.8.842","article-title":"Mortality in randomized trials of antioxidant supplements of primary and secondary prevention: Systematic review and meta-analysis","volume":"297","author":"Bjelakovic","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.gastrohep.2013.06.005_bib0380","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1046\/j.1440-1746.2003.03156.x","article-title":"N-acetylcysteine in the treatment of non-alcoholic steatohepatitis","volume":"18","author":"Pamuk","year":"2003","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057051300188X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057051300188X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T06:19:37Z","timestamp":1563862777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021057051300188X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S021057051300188X"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2013.06.005","relation":{},"ISSN":["0210-5705"],"issn-type":[{"type":"print","value":"0210-5705"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}